BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17397563)

  • 1. [Methicillin susceptible Staphylococcus aureus bacteremia: epidemiology and prognostic factors. A prospective study 2000-2003].
    Gómez J; García-Vázquez E; Baños R; Canteras M; Ruiz J; Herrero JA; Baños V; Valdés M
    Rev Clin Esp; 2007 Feb; 207(2):57-63. PubMed ID: 17397563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB; Ross T; Gregson DB
    J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study of patients with methicillin susceptible versus methicillin resistant Staphylococcus aureus bacteremia: epidemiology and prognostic factors].
    García-Vázquez E; Gómez J; Baños R; Canteras M; Ruiz J; Baños V; Herrero JA; Valdés M
    Med Clin (Barc); 2007 May; 128(18):681-6. PubMed ID: 17540142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.
    Bassetti M; Trecarichi EM; Mesini A; Spanu T; Giacobbe DR; Rossi M; Shenone E; Pascale GD; Molinari MP; Cauda R; Viscoli C; Tumbarello M
    Clin Microbiol Infect; 2012 Sep; 18(9):862-9. PubMed ID: 21999245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare- and community-associated Staphylococcus aureus bacteraemia.
    Forsblom E; Ruotsalainen E; Mölkänen T; Ollgren J; Lyytikäinen O; Järvinen A
    J Hosp Infect; 2011 Jun; 78(2):102-7. PubMed ID: 21511366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and outcomes of community-onset methicillin-susceptible Staphylococcus aureus bacteraemia in a university hospital in Singapore.
    Chia JW; Hsu LY; Chai LY; Tambyah PA
    BMC Infect Dis; 2008 Feb; 8():14. PubMed ID: 18254979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteremia by Staphylococcus aureus: analysis of 311 episodes].
    Rubio M; Romero J; Corral O; Roca V; Picazo JJ
    Enferm Infecc Microbiol Clin; 1999 Feb; 17(2):56-64. PubMed ID: 10193063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology, course and prognosis of Staphylococcus aureus bacteremia--Preliminary results from the INSTINCT (INvasive STaphylococcus aureus INfection CohorT) cohort].
    Seifert H; Wisplinghoff H; Kaasch A; Achilles K; Langhorst A; Peyerl-Hoffmann G; Woehrmann A; Fätkenheuer G; Salzberger B; Kern WV
    Dtsch Med Wochenschr; 2008 Feb; 133(8):340-5. PubMed ID: 18270913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy.
    Gómez J; García-Vázquez E; Baños R; Canteras M; Ruiz J; Baños V; Herrero JA; Valdés M
    Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):239-45. PubMed ID: 17318479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review.
    Robinson JO; Pearson JC; Christiansen KJ; Coombs GW; Murray RJ
    Eur J Clin Microbiol Infect Dis; 2009 Apr; 28(4):353-61. PubMed ID: 18850122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
    Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: risk factors for acquisition, clinical features and outcome.
    Lin JC; Yeh KM; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2004 Feb; 37(1):24-8. PubMed ID: 15060683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
    Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
    Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
    Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary?
    Pigrau C; Rodríguez D; Planes AM; Almirante B; Larrosa N; Ribera E; Gavaldà J; Pahissa A
    Eur J Clin Microbiol Infect Dis; 2003 Dec; 22(12):713-9. PubMed ID: 14605943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of community-acquired Staphylococcus aureus bacteremia.
    Chi CY; Wong WW; Fung CP; Yu KW; Liu CY
    J Microbiol Immunol Infect; 2004 Feb; 37(1):16-23. PubMed ID: 15060682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia.
    Hounsom L; Grayson K; Melzer M
    Postgrad Med J; 2011 Nov; 87(1033):757-62. PubMed ID: 21798969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit.
    Kuint J; Barzilai A; Regev-Yochay G; Rubinstein E; Keller N; Maayan-Metzger A
    Eur J Pediatr; 2007 Apr; 166(4):319-25. PubMed ID: 17051356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates.
    Kok J; O'Sullivan MV; Gilbert GL
    J Hosp Infect; 2011 Oct; 79(2):108-14. PubMed ID: 21741724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
    Melzer M; Eykyn SJ; Gransden WR; Chinn S
    Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.